White Papers
Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
How to identify and engage with digital opinion leaders
mike.hammerton@pharmaphorum.com
digital, KOL, Within3
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
5 best practices for improving patient engagement
mike.hammerton@pharmaphorum.com
Life Sciences, Medical affairs, patient engagement, Within3
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
Switch on to The Age of Coaching
mike.hammerton@pharmaphorum.com
60 Seconds, pharma, sales coaching
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
Sales coaching: preparing for the new reality in pharma
mike.hammerton@pharmaphorum.com
60 Seconds, COVID-19, Pharma Sales, sales coaching, sales representatives
0 Comment
Digital/ Insights/ Insights/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
Utilising content metrics to improve digital engagement
mike.smith@pharmaphorum.com
content metrics, digital marketing, HCP engagement, pharma marketing, Veeva Systems
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
Transform patient experience with intelligent hyper-personalisation
mike.hammerton@pharmaphorum.com
customer engagement, customer experience, Customer Experience in Pharma, digital HCP engagement, HCP engagement, Indegene, Optimizing customer experience, remote HCP engagement
0 Comment
Digital/ Insights/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
4 ways emerging pharma companies can harness marketing content
mike.hammerton@pharmaphorum.com
content marketing, HCP engagement, marketing, pharma marketing, Veeva
0 Comment
Oncology/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
How pharma can help the post-COVID recovery of European cancer care
mike.hammerton@pharmaphorum.com
Accord Healthcare, cancer, COVID-19, Oncology
0 Comment